Compare ImmunityBio Inc. Common Stock (IBRX) vs Kingsoft Cloud Holdings Limited (KC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Kingsoft Cloud Holdings Limited — how do they compare? ImmunityBio Inc. Common Stock trades at $10.02 (market cap $10.33B), while Kingsoft Cloud Holdings Limited trades at $9.01 (market cap $2.79B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 3.7× Kingsoft Cloud Holdings Limited's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Kingsoft Cloud Holdings Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Kingsoft Cloud Holdings Limited for 12 Days on average.
| IBRX | KC | |
|---|---|---|
Market Cap | $10.33B | $2.79B |
Volume | 11,745,198 | 455,225 |
Sector | Health | Technology |
52-Week High | $11.55 | $18.21 |
52-Week Low | $1.98 | $8.58 |
Typical Hold Time | 0 Days | 12 Days |
Enterprise Value | $10.79B | $3.11B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Kingsoft Cloud (KC) trades at $9.23, down 1.28% today, amid bearish technical signals despite recent earnings beats. The company shows improving fundamentals with Q2 2026 revenue growth of 30.8% year-over-year and positive adjusted operating profit for the first time. Analyst sentiment remains bullish with 70% buy ratings and a consensus price target suggesting 60.3% upside potential. However, the stock faces headwinds from negative net income margins and competitive pressures in China's cloud market.
The outlook balances strong AI-driven growth potential against persistent profitability challenges. Investment opportunity lies in KC's accelerating AI cloud services, which saw 82% year-over-year billing growth, while risks include ongoing losses, high capital expenditure requirements, and US-China regulatory tensions. The stock's current valuation at 1.67x sales appears reasonable given growth trajectory but requires sustained margin improvement for sustained upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Kingsoft Cloud Holdings Limited
Kingsoft Cloud is a leading independent cloud service provider in China. It offers a comprehensive suite of cloud products and solutions tailored for industries like gaming, video streaming, and financial services.
Read more on KC →
